RE:RE:RE:RE:RE:RE:Get out before it all comes crashing downThank you for answer, but I am more willing to heard from CNINVESTING
lt seems Lattice you are CN investing. are u using 2 counts in this board?
and rate the comment as the 5 star
LatticeInExiIe wrote: derekli wrote: why eps miss???
CNInvesting wrote: Numbers may not lie but tey can be deceptive. I wasn't referring to a revision of EBITDA but a plain EPS miss, which will lead the SP down without a doubt. In any case, my point was more a suggestion that it would be wise to hedge considering the known volatility. With the share price movement these past months, why wouldn't you want to hedge ? It's plain common-sense at this stage.
Hi derekii, RBCCM sent out a report Friday (July 29th) with an adjusted eps of $1.26. The Consensus is $1.49 (FactSet: 7 analysts) stating "Our revisions are due to recent Rx trends in CXRX's US business outlined in more detail int eh remainder of the note and FX impacton the AMCo business."
Doug Meihm of RBCCM and Alan RIdgeway have been the analysts that have been "on" their eps estimates, and on the last two earnings they have revised their adj eps 2 weeks into Q release, which suggests to me that they are likely tipped. To my knowledge Ridgeway has not adjusted his eps estimate.